Risk of new primaries after chemotherapy and/or tamoxifen treatment for early breast cancer.

Keywords

Tamoxifen, Medicine, Breast cancer, Chemotherapy, Incidence (geometry)

References

• Use of tamoxifen for breast cancer: twenty-eight years later.Ishmael Jaiyesimi, Aman U. Buzdar, David A. Decker — 1995
• Leukemia in breast cancer patients following adjuvant chemotherapy or postoperative radiation: the NSABP experience.Bernard Fisher, Howard E. Rockette, Edwin R. Fisher — 1985
• Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, estrogen receptor-positive breast cancer patients: results of a multicentric Italian study. Breast Cancer Adjuvant Chemo-Hormone Therapy Cooperative Group.Francesco Boccardo, A. Rubagotti, Paolo Bruzzi — 1990
• Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, oestrogen-receptor positive breast cancer patients. An update at 7 years of the 1st GROCTA (Breast Cancer Adjuvant Chemo-Hormone Therapy Cooperative Group) trial.Francesco Boccardo, A. Rubagotti, D. Amoroso — 1992
• Second Neoplasms After Adjuvant Chemotherapy for Operable Breast CancerMichele K. Herring, Aman U. Buzdar, Terry L. Smith — 1986
• Incidence of new primary cancers after adjuvant tamoxifen therapy and radiotherapy for early breast cancer.Michael Andersson, Hans H. Storm, Henning T. Mouridsen — 1991
• Bioassay program for carcinogenic hazards of cancer chemotherapeutic agentsElizabeth K. Weisburger — 1977
• Carcinogenic activity in rats of combined treatment with cyclophosphamide, methotrexate and 5‐fluorouracilMichael Habs, D. Schmähl, Pengxin Lin — 1981
• Interaction of anticancer drugs with hepatic monooxygenase enzymes.Gerald A. Le Blanc, David J. Waxman — 1989
• Impact of radiation therapy and/or chemotherapy on the risk for a second malignancy after breast cancerRobert S. Lavey, Nancy Eby, Leonard R. Prosnitz — 1990
• A method of analysis taking into account competing events: application to the study of digestive complications following irradiation for cervical cancer.Andrew Kramar, Marie‐Hélène Pejovic, D. Chassagne — 1987
• Re: Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.M. L. Carcangiu — 1994
• Adjuvant chemotherapy in early breast cancer and incidence of new primary malignancies.R. Arriagada, Lars Erik Rutqvist — 1991
• Improved methodology for analyzing local and distant recurrence.Rebecca Gelman, RD Gelber, I. Craig Henderson — 1990
• Effects of tamoxifen on human breast cancer cell cycle kinetics: accumulation of cells in early G1 phase.C. Kent Osborne, David H. Boldt, Gary M. Clark — 1983
• Two-year carcinogenicity study of tamoxifen in Alderley Park Wistar-derived rats.Peter Greaves, Rajiv Goonetilleke, Graham R. Nunn — 1993
• Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse.Marco M. Gottardis, Simon P. Robinson, P.G. Satyaswaroop — 1988
• Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. Stockholm Breast Cancer Study Group.Lars Erik Rutqvist, Hemming Johansson, T. Signomklao — 1995
• Second malignancies following CMF-based adjuvant chemotherapy in resectable breast cancer.Pinuccia Valagussa, Angela Moliterni, Monica Terenziani — 1994
• Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers.Tommy� Fornander, Björn Cedermark, Anders Mattsson — 1989

Cited by

• Risk Factors for Colorectal Cancer Following Breast CancerLeanne Kmet, Linda S. Cook, Noel S. Weiss — 2003
• Tamoxifen and the female genital tract.Ugwumadu, Paul L. Carmichael, Neven — 1998
• Ovarian cancer risk in premenopausal and perimenopausal women treated with Tamoxifen: a case–control studyfor the British Tamoxifen Second Cancer Study Group, Anthony J. Swerdlow, Michael E. Jones — 2007
• Emerging Role of Capecitabine in Gastric CancerPasquale Camella, Luca Franco, Rossana Casaretti — 2009
• Lung nodules in a woman with a history of breast cancer. Diagnosis: a sarcoid-like reaction in metastatic breast cancer.Michael G. Risbano, Steve D. Groshong, Marvin I. Schwarz — 2007
• Radiation dose, chemotherapy, hormonal treatment and risk of second cancer after breast cancer treatmentCorrado Rubino, Florent de Vathaire, A. Shamsaldin — 2003
• Emerging biological therapies for pancreatic carcinoma.Andrew D. Gilliam, Susan A. Watson — 2002
• Capecitabine, Alone and in Combination, in the Management of Patients with Colorectal CancerPasquale Comella, Rossana Casaretti, Claudia Sandomenico — 2012
• Second cancers after conservative surgery and radiation for stages I-II breast cancer: identifying a subset of women at increased risk.Barbara Fowble, Alexandra L. Hanlon, Gary M. Freedman — 2001
• Other Primary Malignancies in Breast Cancer Patients Treated with Breast Conserving Surgery and Radiation TherapyMin Yi, Janice N. Cormier, Yan Xing — 2012
• Second cancers after breast cancer treatment.Sister Mary A. Matesich, Charles L. Shapiro — 2003
• Randomised trial comparing biweekly oxaliplatin plus oral capecitabine versus oxaliplatin plus i.v. bolus fluorouracil/leucovorin in metastatic colorectal cancer patients: results of the Southern Italy Cooperative Oncology study 0401Pasquale Comella, B. Massidda, Gianfranco Filippelli — 2009
• Side effects of adjuvant treatment of breast cancer.Charles L. Shapiro, Abram Recht — 2001
• Controversies regarding tamoxifen and uterine carcinoma.Patrick Neven, Ignace Vergote — 1998
• S IDE E FFECTS OF A DJUVANT T REATMENT OF B REAST C ANCERC Harles L. S Hapiro, A Bram R Echt — 2001
• HAWAI'I MEDICAL JOURNALKenric M. Murayama — 2007
• Association between breast cancer and the risk of colorectal cancer.Jennifer Lai, Gavin Park, Lauren B. Gerson — 2017
• Acute Myeloid Leukemia After Treatment of Early Breast Cancer: Case Report and Literature ReviewIssam Lalya, Ismail Essâdi, Rhizlane Belbaraka — 2019
• Incidence of second primary malignancies in women with different stages of breast cancerCheng-Yao Lin, Sheng‐Yen Hsiao, Wen‐Tsung Huang — 2023
• Secondary Primary Cancer after Cancer and Immunosuppressive Chemotherapy and RadiotherapyJ. Soedirman — 2000

Related papers

• EDITORIALS Tamoxifen and Contralateral Breast Cancer: the Other SideSandra M. Swain — 2014
• Clinical efficacy of tamoxifen.Nicholas J. Robert — 1997
• Adjuvant treatment for breast cancer in the elderly.P Marchei, Bianco, E Pignatelli — 1996
• Predicting Prognosis and Tamoxifen Response in Breast Cancer. With a special focus on contralateral breast cancer.Sara Alkner — 2012
• The place of chemotherapy in the treatment of early breast cancer.A. Buzdar — 1998
• The Response to Neoadjuvant Chemotherapy Predicts Clinical Outcome and Increases Breast Conservation in Advanced Breast CancerPhilip M. Spanheimer, Jennifer C. Carr, Alexandra Thomas — 2013
• Clinical significance of CYP2D6 polymorphisms and tamoxifen in women with breast cancer.Cindy Gaston, Jill Kolesar — 2008
• Relationships between CYP2D6 phenotype, breast cancer and hot flushes in women at high risk of breast cancer receiving prophylactic tamoxifen: results from the IBIS-I trialIvana Šestak, Roseann Kealy, Michele Nikoloff — 2012